AI assistant
ClearPoint Neuro, Inc. — Director's Dealing 2012
Feb 27, 2012
32641_dirs_2012-02-27_28ede1b3-e8cc-4fcf-b39e-50f1522877ec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MRI INTERVENTIONS, INC. (NONE)
CIK: 0001285550
Period of Report: 2012-02-27
Reporting Person: PIETRANGELO MICHAEL (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 48263 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants (right to buy) | $0.01 | 2013-09-14 | Common Stock (25000) | Direct | |
| Option (right to buy) | $1.80 | 2020-12-13 | Common Stock (38000) | Direct | |
| Option (right to buy) | $1.80 | 2020-12-13 | Common Stock (12000) | Direct |
Footnotes
F1: The shares subject to this warrant are immediately exercisable.
F2: One-third of the shares subject to this option vested on the first anniversary of the grant date, December 13, 2011. The remaining shares subject to this option vest ratably on the second and third anniversaries of the grant date, December 13, 2012 and December 13, 2013.
F3: The shares subject to this option vest ratably on the first, second and third anniversaries of the grant date, December 13, 2011, December 13, 2012 and December 13, 2013, provided that no shares vest until such time as the company closes a target equity financing, which is defined as one or more equity financing transactions that results in cumulative gross proceeds of at least $10 million.